Great time at #IDWeek2025! 1️⃣ Reconnecting with friends 2️⃣ Honored to be inducted as a FIDSA alongside one of my favorite WashU seniors 3️⃣ Grateful to present our collaborative work with Massachusetts DPH on the statewide Antibiotic Start Reporting Program in long-term care

Thrilled to share our new publication on #penicillinallergy #delabeling practices and barries across SHEA SRN institutions. We found wide variability in practices, with barriers eg limited EHR integration, and lack of outcome tracking. https://t.co/ZvgglAkc1M

Excited to share our Letter to the Editor urging caution on adopting plasma #mNGS for #NHSN #CLABSI surveillance, highlighting why it may not be ready for prime time. Grateful to my co-authors for their insights. https://t.co/yBljiiBFFx

Happy to have contributed to the Clinical Dilemmas in Infectious Diseases series in CID. Grateful for the opportunity to share this challenging case and the lessons it offers for clinical practice. https://t.co/Cji30JqT6S

Honored to be elected a Fellow of the Infectious Diseases Society of America (FIDSA) this year! Grateful for the support and nomination from Drs. Deb Poutsiaka and Shira Doron. #IDSA https://t.co/YPh2ykGGI8

Excited to share our commentary on #PenicillinAllergy delabeling in long-term care facilities—if not now, then when? We explore gaps, barriers, and actionable solutions for #Delabeling in this vulnerable population! #Geriatrics https://t.co/OghMx7sxhE @ShiraDoronMD @IDDoc1978

Excited to share our new publication! Our findings show incomplete beta-lactam #allergy documentation increases the risk of prescribing antibiotics most associated with #Cdiff infection in long-term care residents.#delabeling @ShiraDoronMD @IDDoc1978 https://t.co/lx5EUUOPdY

Thank you for the shout-out!

2023-2024 LEAP Fellows #IDWeek2024

@ASHE_Journal

Thrilled to share our latest LEAP work on #penicillin #allergy and beta-lactam use in Massachusetts LTC facilities, offering insights into penicillin allergy #delabeling in this population. @ShiraDoronMD @IDDoc1978 https://t.co/xFSi8wqTRp

Excited to share our latest publication in the Journal of Infection! We explored the IL-6 hypothesis in severe and critical COVID-19 using Sirukumab. https://t.co/cr2cPmVmjH

Thrilled to share our collaborative work with the Masschusetts DPH: Antibiotic Allergy Prevalence and Documentation Quality in Massachusetts Long-Term Care Facilities:A Cross-Sectional Survey @ShiraDoronMD @IDDoc1978 #antibioticallergy #penicillinallergy https://t.co/5bm0RBzqMu

I’m thrilled and honored to be one of the four recipients of the 2023-24 #LEAPfellowship award from #IDSA. Grateful for the senior mentorship support (@ShiraDoronMD) from #TuftsMC, and Iooking forward to partnering with the Massachusetts Department of Public Health!

We have unfilled #IDfellowship spots @WUSTLmed If you are interested in ID consider joining us in beautiful St Louis! World class research, friendly collegial environment and the best profession! #IDTwitter #match2022 #MedTwitter

Excited to share our work published in #OFIDJournal Clinical Impact of #KariusTest in the diagnosis and management of #pneumocystis pneumonia and coinfections https://t.co/YMDZibIXuM

Check out our new publication! Wide variations and gaps in blood culture ordering practices among hospitalized patients with fever and hypothermia. #DiagnosticStewardship

Updated Shorter Is Better tables with new (13th!!!) CAP trial! https://t.co/GTEBUJEUYn

Got my #covidvaccine today! 👍🏻

#Remdesivir begins distribution in the #USA today via #EUA. I thought would write down some practical #tips based on my #qualitative anecdotal experience after personally treating close to 200 patients with #COVID19. For quantitative results, wait for the papers¬—thread